TrialDiabetes, obesity & metabolism2017

Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes.

David Preiss et al.PubMed ↗Full text ↗Publisher ↗

A later paper about NCT00723307. The trial’s primary report, PMID 24622715, speaks for it on the map; the numbers here are shown and do not vote.

No numbers read from the abstract.